Published in Allergy on January 20, 2011
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med (2012) 1.08
Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol (2013) 1.06
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy (2012) 0.87
Sublingual immunotherapy in allergic rhinitis. Asia Pac Allergy (2011) 0.85
Mechanisms of peptide immunotherapy in allergic airways disease. Ann Am Thorac Soc (2014) 0.78
Therapeutic effects and biomarkers in sublingual immunotherapy: a review. J Allergy (Cairo) (2012) 0.77
Oral CD103(-)CD11b(+) classical dendritic cells present sublingual antigen and induce Foxp3(+) regulatory T cells in draining lymph nodes. Mucosal Immunol (2016) 0.76
Novel developments in the mechanisms of immune tolerance to allergens. Hum Vaccin Immunother (2012) 0.76
Developing therapies for peanut allergy. Int Arch Allergy Immunol (2014) 0.76
FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy. J Immunol Res (2015) 0.75
Oral mucosal immunotherapy for allergic rhinitis: A pilot study. Allergy Rhinol (Providence) (2016) 0.75
Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity. Sci Rep (2017) 0.75
Comparative phenotypic and functional analysis of migratory dendritic cell subsets from human oral mucosa and skin. PLoS One (2017) 0.75
Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials. Front Immunol (2017) 0.75
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97
A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res (1999) 3.19
A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med (1997) 2.29
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Loss-of-function mutations in the filaggrin gene and allergic contact sensitization to nickel. J Invest Dermatol (2007) 2.04
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol (2005) 1.54
Early markers for protective mechanisms during rush venom immunotherapy. Allergy (2010) 1.50
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol (2001) 1.45
Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients. Allergy (2003) 1.44
Leprosy type 1 reaction as the first manifestation of borderline lepromatous leprosy in a young native German. Br J Dermatol (1997) 1.39
[Atopic dermatitis. Version (17 July 2002 - modified final version)]. J Dtsch Dermatol Ges (2003) 1.39
Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy (2007) 1.39
New treatment modalities for granuloma faciale. Br J Dermatol (2003) 1.31
Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol (1996) 1.31
Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol (2006) 1.22
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
Management of dermatofibrosarcoma protuberans with fibrosarcomatous transformation: an evidence-based review of the literature. J Eur Acad Dermatol Venereol (2011) 1.18
Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy (2008) 1.14
The high-affinity IgE receptor (FcepsilonRI) blocks apoptosis in normal human monocytes. J Clin Invest (2000) 1.10
Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol (2005) 1.10
CD1 expression is not affected by human peptide transporter deficiency. Hum Immunol (1994) 1.07
4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man. Int J Clin Pharmacol Ther (2009) 1.05
Sporotrichoid phaeohyphomycosis due to Alternaria infectoria. Br J Dermatol (2001) 1.04
Comparative analysis of nasal and oral mucosa dendritic cells. Allergy (2006) 1.02
Atopic dermatitis - from new pathophysiologic insights to individualized therapy. Allergy (2011) 1.01
Analysis of the high affinity IgE receptor genes reveals epistatic effects of FCER1A variants on eczema risk. Allergy (2009) 1.01
The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol (2007) 0.99
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.99
Human epidermal Langerhans cells internalize by receptor-mediated endocytosis T6 (CD1 "NA1/34") surface antigen. Birbeck granules are involved in the intracellular traffic of the T6 antigen. J Invest Dermatol (1987) 0.97
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy (2007) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement. Allergy (2011) 0.95
Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol (2008) 0.95
Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells. J Immunol (2001) 0.95
Generation of dendritic cell-based vaccines for cancer therapy. Br J Cancer (2002) 0.94
Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, Fc epsilon RI. J Immunol (1995) 0.94
Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol (2005) 0.94
On treating male homosexuals. Arch Gen Psychiatry (1967) 0.92
Successful treatment of acrodermatitis continua suppurativa with topical tacrolimus 0.1% ointment. Br J Dermatol (2004) 0.92
Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Allergy (2011) 0.92
New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol (2010) 0.92
Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol (2000) 0.92
In search for predictive factors for atopy in human cord blood. Allergy (2005) 0.91
5-Lipoxygenase expression in Langerhans cells of normal human epidermis. Proc Natl Acad Sci U S A (1998) 0.90
Characterization of different courses of atopic dermatitis in adolescent and adult patients. Allergy (2013) 0.90
Antigen-presenting cells in allergy. J Allergy Clin Immunol (2001) 0.90
Atopic dermatitis: from the genes to skin lesions. Allergy (2000) 0.90
Membrane and soluble Fc gamma RII/III modulate the antigen-presenting capacity of murine dendritic epidermal Langerhans cells for IgG-complexed antigens. J Immunol (1995) 0.89
Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol (1991) 0.89
HLA-G: expression in human keratinocytes in vitro and in human skin in vivo. Eur J Immunol (1994) 0.89
Decreased gene expression of human beta-defensin-1 in the development of squamous cell carcinoma of the oral cavity. Int J Oral Maxillofac Surg (2008) 0.89
Proactive therapy of atopic dermatitis--an emerging concept. Allergy (2008) 0.89
Clinical and biological effects of balneotherapy with selenium-rich spa water in patients with psoriasis vulgaris. Br J Dermatol (1995) 0.89
In situ expression of the costimulatory molecules CD80 and CD86 on langerhans cells and inflammatory dendritic epidermal cells (IDEC) in atopic dermatitis. Arch Dermatol Res (2001) 0.88
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trial. Hum Gene Ther (2001) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88
Human skin and oral mucosal dendritic cells as 'good guys' and 'bad guys' in allergic immune responses. Clin Exp Immunol (2010) 0.87
Embolia cutis medicamentosa of the foot after sclerotherapy. Eur J Dermatol (1999) 0.87
Human epidermal Langerhans' cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol (2001) 0.86
The central role of FcepsilonRI in allergy. Clin Exp Dermatol (2003) 0.86
Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy (2004) 0.86
Human epidermal Langerhans cells express only the 40-kilodalton Fc gamma receptor (FcRII). J Immunol (1990) 0.86
IgE receptors. Curr Opin Immunol (2001) 0.86
The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy. Allergy (2012) 0.86
Toll-like receptor 7 agonists and skin. Drug News Perspect (2008) 0.86
Analysis of four prevalent filaggrin mutations (R501X, 2282del4, R2447X and S3247X) in Austrian and German patients with atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
Mucosal dendritic cells in allergy and immunotherapy. Allergy (2011) 0.86
Pyoderma gangrenosum: another cutaneous side-effect of sunitinib? Br J Dermatol (2008) 0.86
Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy (2006) 0.85
The mode of topical immunomodulators in the immunological network of atopic dermatitis. Clin Exp Dermatol (2005) 0.85
Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol (2012) 0.85
Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br J Dermatol (2005) 0.85
[Multiple skin cancers in a patient treated with hydroxyurea]. Hautarzt (2009) 0.84
A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol (2005) 0.84
Tolerogenic T cells, Th1/Th17 cytokines and TLR2/TLR4 expressing dendritic cells predominate the microenvironment within distinct oral mucosal sites. Allergy (2010) 0.84
Effects of high-dose itraconazole treatment on lipoproteins in men. Int J Clin Pharmacol Ther (2007) 0.84
Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome. Clin Exp Dermatol (2005) 0.84
Immunodeviation towards a Th17 immune response associated with testicular damage in azoospermic men. Int J Androl (2011) 0.84
Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J Immunol (1994) 0.84
Dendritic cells in allergy. Allergy (1999) 0.83
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.83
Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol (1998) 0.83
Important questions in allergy: novel research areas. Allergy (2008) 0.83
Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol (2000) 0.83
Gardner-Diamond syndrome: a rare differential diagnosis of child abuse. Br J Dermatol (2011) 0.83
Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate. Br J Dermatol (2001) 0.83
Phenotyping of epidermal dendritic cells: clinical applications of a flow cytometric micromethod. Cytometry (1999) 0.82
Langerhans cells of the human skin possess high-affinity 12(S)-hydroxyeicosa tetraenoic acid receptors. Eur J Immunol (1992) 0.82
Chilblain lupus erythematosus Hutchinson: successful treatment with mycophenolate mofetil. Arch Dermatol (2001) 0.82
Neuropeptide blood levels correlate with mast cell load in patients with mastocytosis. Allergy (2011) 0.82